de Bony F, Bidault R, Peck R, Posner J
Department of Clinical Pharmacology, Laboratoires Wellcome, Issy les Moulineaux, France.
J Antimicrob Chemother. 1996 Feb;37(2):383-7. doi: 10.1093/jac/37.2.383.
Valaciclovir is rapidly and extensively converted to acyclovir. In this study we investigated the potential interaction between oral valaciclovir and Maalox. On each of three occasions 18 healthy volunteers received a single oral dose of 1000 mg valaciclovir, or 30 mL Maalox 65 min after valaciclovir administration, or 30 mL Maalox 30 min before valaciclovir. Acyclovir plasma concentrations and pharmacokinetic parameters were not significantly affected by administration of Maalox before or after valaciclovir. Therefore, there is no need for restriction of valaciclovir dosing in patients receiving antacid medication.
伐昔洛韦能迅速且广泛地转化为阿昔洛韦。在本研究中,我们调查了口服伐昔洛韦与氢氧化铝镁混悬液之间的潜在相互作用。18名健康志愿者在三个不同时段分别接受了单次口服1000mg伐昔洛韦,或在服用伐昔洛韦65分钟后服用30mL氢氧化铝镁混悬液,或在服用伐昔洛韦30分钟前服用30mL氢氧化铝镁混悬液。阿昔洛韦的血浆浓度和药代动力学参数在伐昔洛韦之前或之后服用氢氧化铝镁混悬液时均未受到显著影响。因此,接受抗酸药物治疗的患者无需限制伐昔洛韦的剂量。